FDA Inspection 1078725 — LABORATOIRE BNK CANADA INC
The FDA completed an inspection of LABORATOIRE BNK CANADA INC on Jan 23, 2019 in Montreal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montreal (Canada)
Additional Details
Clinical BA/BE